This Parkinson’s disease clinical trial may be of interest to those exploring research-based treatment options. ClinicalTrials.gov ID: NCT07106021 Study Type: Phase 1b/2a, open-label, interventional Investigational Therapy: RNDP-001 (dopaminergic stem cell replacement) Delivery Method: Intraputamenal neurosurgical implantation Primary Objective: Safety and tolerability Secondary Outcomes: Motor function and neuroimaging changes over time Recruiting Locations: 📍 Keck Medical Center of USC – Los
1:24
This Parkinson’s disease clinical trial may be of interest to those exploring research-based treatment options. ClinicalTrials.gov ID: NCT07106021 Study Type: Phase 1b/2a, open-label, interventional Investigational Therapy: RNDP-001 (dopaminergic stem cell replacement) Delivery Method: Intraputamenal neurosurgical implantation Primary Objective: Safety and tolerability Secondary Outcomes: Motor function and neuroimaging changes over time Recruiting Locations: 📍 Keck Medical Center of USC – Los
16,3K weergaven7 maanden geleden
FacebookReka Janisse
Meer weergeven
Statische miniatuurweergave plaatsaanduiding